
7wire Ventures
About
7wire builds and invests in early-stage, digital health companies dedicated to creating Informed Connected Health Consumers.
Financial History
Leadership Team
Key people at 7wire Ventures.

7wire builds and invests in early-stage, digital health companies dedicated to creating Informed Connected Health Consumers.
Key people at 7wire Ventures.
Key people at 7wire Ventures.
7wire Ventures is a Chicago-based venture capital firm focused on investing in early-stage digital health companies that empower consumers to take control of their health through innovative, tech-enabled solutions. Their mission centers on transforming patients into informed, connected health consumers by supporting ventures that improve health outcomes, accessibility, and affordability. The firm targets sectors including healthtech, wellness, biotech, and software applications, with notable portfolio companies such as Livongo (chronic care management), NOCD (virtual therapy for OCD), FOLX Health (LGBTQIA+ virtual healthcare), and Brightline (behavioral health for children and families). With over $500 million in assets under management, including a recent $217 million Growth & Opportunity Fund, 7wire Ventures plays a significant role in advancing consumer-first healthcare innovation[1][3][4].
Founded in 2011 by Glen Tullman and Lee Shapiro, 7wire Ventures evolved from a focus on early-stage digital health investments to also include building companies from scratch through its Hatch program, which incubates ideas based on deep healthcare consumer insights. The founders bring extensive healthcare and investment experience, with Shapiro notably serving as the American Heart Association board chairperson. The firm’s evolution reflects a commitment to rewiring the healthcare status quo by fostering interconnectedness and interaction between consumers and care systems[1][2][3].
7wire Ventures rides the wave of digital transformation in healthcare, capitalizing on trends such as consumer empowerment, virtual care, and data-driven personalized medicine. The timing is critical as healthcare systems face increasing demand for accessible, affordable, and patient-centered solutions. By focusing on consumer-first health technologies, 7wire influences the ecosystem by accelerating adoption of digital health tools that improve outcomes and reduce costs, helping to reshape healthcare delivery in the U.S. and beyond[3][4].
Looking ahead, 7wire Ventures is poised to deepen its impact by leveraging its Growth & Opportunity Fund to support scaling companies in Series B and C rounds. Trends like AI-powered health tools, behavioral health innovation, and inclusive care models will likely shape their investment focus. Their dual role as creators and investors positions them uniquely to continue driving systemic improvements in healthcare, reinforcing their mission to rewire the status quo and empower health consumers on a broad scale[1][3][4].